Autoimmunity: Alopecia Areata

    Maria Hordinsky, Marna E. Ericson
    TLDR Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.
    Alopecia areata (AA) was identified as an autoimmune disease characterized by nonscarring hair loss, often associated with other autoimmune conditions. The presence of autoreactive T lymphocytes supported its autoimmune etiology, with both CD4+ and CD8+ T cells playing roles in its pathogenesis. Studies showed that AA could be transferred to human scalp explants on SCID mice using T lymphocytes, indicating a T cell-mediated mechanism. Immune modulating drugs, such as corticosteroids, were beneficial in managing AA. Genetic predisposition was suggested by associations with certain HLA alleles, and AA was observed to have a protective effect against Type I diabetes. Animal models were used to study AA's pathophysiology and test therapies. Neuropeptides and altered cutaneous innervation were implicated, with a pilot study using capsaicin cream showing vellus hair regrowth. The document emphasized the need for further research into treatments and genetic studies.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results